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Mitochondrial apoptotic pathway is precisely controlled by BCL-2 family. Complex interactions of
BCL-2 family proteins constitute a bistable switch of which detailed experimental and theoretical
delineation remains elusive. In this paper, combined approaches were used to explore the bistability
of Bax activation switch. We found that Bax activation is indeed in an ‘all-or-none’ manner. The ‘var-
iable-delay, snap-action’ nature for Bax activation is further explored theoretically. We suggest that
bistability is largely attributed to topological structure and shows considerable robustness. There-
fore, our study characterizes dynamics and sensitivities in intrinsic apoptotic pathway.
Crown Copyright  2010 Published by Elsevier B.V. on behalf of Federation of European Biochemical
society. All rights reserved.1. Introduction Although two major models and recently a unifying model haveApoptosis has attracted great attention in recent years. Besides
ligand binding which triggers the extrinsic pathway, the intrinsic
(mitochondria) pathway is provoked by the complex interactions
among BCL-2 family members [1]. These proteins display a range
of activities and can be further grouped into three classes [1,4].
One class, named anti-apoptotics, which inhibit apoptosis covers
BCL-2, BCL-XL, BCL-W, MCL1, BCL-B and A1, whereas another class
called pro-apoptotics promotes apoptosis (Bax, Bak and Bok). The
third class termed BH3-only proteins (e.g. Bim, Bad, Bid, Bik, Bmf,
Puma, Noxa) serve as upstream sentinels and respond to diverse
death signals. Upon stimulation, selected BH3-only proteins either
dissociate pro-apoptotics from the sequestration of anti-apoptotics
(enabler) or directly activate Bax and Bak (activator), which then
oligomerize and form permeabilization pores on mitochondria out-
er membrane and ﬁnally invoke mitochondria outer membrane
permeabilization (MOMP) [2]. Multiple apoptogenic factors are re-
leased from mitochondria inter-membrane space and then trigger
apoptosis. Thus, the importance of BCL-2 family motivates numer-
ous investigations.d by Elsevier B.V. on behalf of Fede
, mitochondrial outer mem-
tosis channel; MII, mutualbeen proposed [3–6], these cast no doubt on the role of BCL-2 fam-
ily as upstream switch during commitment to apoptosis [7], and
we have found intricate interactions among BCL-2 family proteins
confer bistability [8,9]. Bistability contributes to cell decision be-
tween alternative states, especially, life and death. It is unclear
whether BCL-2 regulatory network is experimentally conﬁrmed
as bistable system and what structural characteristics are respon-
sible for bistability. Therefore, the emergent properties of bistabil-
ity merit further investigation. Bifurcation analysis can well
characterize the all-or-none patterns for bistability. But conven-
tional bifurcation analyses rely on deterministic approaches, while
cellular environment is noisy where stochasticity should be con-
sidered. Few models performed bifurcation analysis with stochas-
tic approaches. Therefore, the stochasticity in bifurcation will
provide crucial insights into BCL-2 network.
In this study, we identiﬁed BCL-2 regulatory network as bista-
ble, and further provided preliminary evidence on bistable Bax
activation experimentally. Furthermore, we characterized an acti-
vation status termed ‘variable-delay, snap-action’ theoretically.
As biological systems are pervaded with parametric uncertainty,
we then introduced parameter stochasticity in bifurcation analysis
and found that static bifurcation shifts signiﬁcantly. We further
elucidated that bistability shows less sensitivity to most parame-
ters and further identiﬁed robustness and fragile properties for
Bax activation switch with an entropy based method. Finally, we
found that threshold show much more variability while the steady
state of activated Bax is relatively refractory, thus again indirectly
conﬁrmed the ‘variable-delay, snap-action’ pattern.ration of European Biochemical society. All rights reserved.
Fig. 2. Bistability for Bax activation switch. (A) Two-parameter bifurcation diagram.
The parameter p1 donates production rate of inactive Bax and p2 represents
production rate of activator type BH3-only proteins. Shaded area identiﬁes a
biological unreachable region. (B) CUSP surface. Note the ‘negative production rate’
is biologically unrealistic but is shown here in consideration of visualization.
T. Sun et al. / FEBS Letters 584 (2010) 954–960 9552. Results
2.1. Positive feedback loops confer bistability
We constructed our model based on our previous model (Fig. 1,
for more details, see Ref. [9]). Our previous work has shown that
the interplay among BCL-2 family members confers bistability
[8,9]. We further extend the model by highlighting bistability in
2D and 3D. The region enclosed by curved edge triangle suggests
bistability, while the region outside describes monostability (p1,
production rate of inactive Bax; p2, production rate of activator,
Fig. 2A). Note that the shaded area means biologically unreachable
region because production rate (i.e. p2) cannot be negative. The ar-
row indicates a critical point on crossing which irreversibility oc-
curs (i.e. one-way switch). In three-dimensional visualization, the
surface folded inside implies bistability (Fig. 2B). When p1 is low,
behavior changes continuously with p2. However, when p1 is high,
a sudden jump happens which implies CUSP catastrophe, there-
fore, conﬁrms bistability.
We further investigated whether Bax activation is indeed bista-
ble in real biological system. A necessary condition for bistability
implies that the response curve should be ultrasensitive. By map-
ping response, we found the dose response can be well approxi-
mated with Hill coefﬁcient 2.377, thus implying ultrasensitivity
(Fig. S1). Furthermore, if bistable, there should appear a bimodal
distribution with proper external stimuli. To explore bimodal Bax
activation, HeLa cells were treated with staurosporine (STS, a ki-
nase inhibitor which can be used to investigate intrinsic apoptotic
pathway [10]) at different concentrations for 6 h and then har-
vested for ﬂow cytometry analysis. Most cells were morphologi-
cally intact even with 1000 nM STS at 6-h time points (>80%
from independent counts, data not shown). Under non-stressed
conditions, no detectable activated Bax can be observed (Fig. 3,
STS 0 nM). Relatively weak stimulation (300 nM) induces minor
Bax activation although bimodal distribution of activated Bax
emerges. An application of 400 nM STS induces a distinguishable
bimodal distribution indicating that individual cells response in
an ‘all-or-none’ manner. However, bimodality was not observed
for cells with relatively high STS doses (1000 nM).
We further referred to bifurcation diagram to qualitatively ex-
plain the observed bimodality (Fig. S2, dashed red lines). For bifur-
cation diagram, we chose p2 (production rate of activator) as
bifurcation parameter (also see sections below). For non-stressed
conditions which probably correspond to basal or low levels of
activator production, the systematic responses will be monostable
(Fig. 3, 0 nM and Fig. S2, ‘no stress’ line). When bifurcation param-
eter invades bistable region, noise induced stochastic transition be-
tween alternative states will lead to bimodal distribution [11]. As
the unstable states characterize threshold (Fig. S2, solid grey
curve), the relatively large gap between unstable and lower stable
steady state do not allow considerable transition, thus distinguish-
able bimodality is not clearly shown (Fig. 3, 300 nM and Fig. S2,
‘weak’ line). Once the gap becomes signiﬁcantly reduced, noise in-Fig. 1. Schematic representation of BCL-2 network. Arrows: activation. Horizontal
bars: inhibition.duced transitions will be facilitated and bimodality can be best ob-
served (Fig. 3, 400 nM and Fig. S2, ‘intermediate’ line). Further
increasing STS levels ﬁnally move the system out of bistable region
and bimodality disappears (Fig. 3, 1000 nM and Fig. S2, ‘strong’
line).
Taken together, simulation results suggest that positive feed-
back loops confer bistability to BCL-2 network. Experiments fur-
ther indicate bimodal distribution, thus implying bistable Bax
activation.
2.2. ‘Snap-action, variable-delay’ activation
Bistability in extrinsic pathway has been modeled for years. Re-
cently, Albeck et al. conﬁrmed that extrinsic apoptosis is controlled
by ‘variable-delay, snap-action’ switch [12]. As Bax activation
switch which primarily contributes to the intrinsic pathway also
suggests bistability, we further speculate that similar dynamical
pattern might occur. We choose p2 (production rate of activator)
as bifurcation parameter because under stressed condition, induc-
tion of PUMA (which was recently identiﬁed as activator type BH3-
only proteins) by STS could be envisioned as increased activator
production [13,14]. We deﬁne the ﬁrst time instance when
summed levels of activator, enabler and activated Bax (pro-apopt-
otics in our model) exceed the Bcl-2 (anti-apoptotics) levels as acti-
vation start, because the anti-/pro-apoptotic ratio (e.g. Bax/Bcl-2
ratio [15]) play essential roles in apoptotic control. Furthermore,
the endpoint is selected as the ﬁrst time instance when activated
Bax level reaches 90% of the deterministic steady state (Fig. S3). Be-
cause the stochastic trajectories are not smoothly differentiable,
Fig. 3. Bimodal Bax activation. Flow cytometry of Bax activation, assayed with an antibody selective for activated Bax (clone 6A7). HeLa cells were treated as described in
methods. Florescence intensity was represented with logarithm scale. At either low or high STS levels, cell population shows unimodal distribution, while intermediate STS
stimulation leads to bimodality. Note that all four panels have the same horizontal scale. Nonzero STS panels (300, 400 and 1000 nM) share the same vertical scale while the
panel corresponds to non-stressed condition (0 nM) is twice the reading on the vertical scale.
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interval between the start and endpoint is the time needed for
activation (Ta). The characteristic delay time (Td) is the time
between zero and Ta start. 1000 (normalized) simulations were
performed and distributions are shown (Fig. 4). We found stimula-
tion elicits signiﬁcantly heterogeneous responses in Td (257.8167 ±
43.6150 min, CV = 0.1692) compared with Ta (15.8618 ± 1.1438
min, CV = 0.0721, Fig. 4). We further elevate stimulation by
increasing p2, but we found qualitatively similar results although
Td becomes more homogenous (data not shown). Results suggest
that on stimulation, the BCL-2 network involve considerable varia-
tions in Td concomitant with relatively stable Ta which character-
izes a ‘variable-delay, snap-action’ pattern.
2.3. Parameter uncertainty in bifurcation patterns
Stochastic models are always required when random events are
encountered. It is universally acknowledged that there is no escape
from the uncertainty regarding kinetic parameters, which might be
varied during the course of simulation [16]. Therefore, we further
explore the parametric stochasticity in biological system.
2.3.1. Mutual information indices characterize a robust switch
Cellular variation may lead to multi-parameter uncertainty,
which means that parameters are perturbed from ‘nominal’ values.
All parameters were varied 20% from nominal values (Table. S3)
with Latin Hypercubic Sampling (1000 sets), and for each set, we
derived associated bifurcation diagram. The perturbed system
was regarded as bistable system if corresponding bifurcation (withbifurcation parameter p2) retains two saddle-node points (Fig. S4).
We found that perturbed systems always have two SN points, no
other types of codimension-1 bifurcation patterns are detected,
which indicate robust bistability (data not shown). As described,
the SN2 points are deﬁned as activation threshold upon crossing
which the state behavior (activated Bax) increases abruptly
(Fig. S4). The perturbed bistable range (Fig. S4) can also be cap-
tured. For steady state sensitivity, we set p2 = 0.015 nM/s (which
is also subject to stochastic ﬂuctuation) as the nominal value for
sufﬁcient long periods to guarantee high steady states. This simpli-
ﬁcation can qualitatively evaluate the high steady state sensitivity
(activated state). To characterize the input-output patterns, we
employed a method based no Shannon’s entropy. Thus, steady
state, bistable range and threshold sensitivity for all parameters
can be obtained.
The mutual information indices reveal that only a small subset
of parameters signiﬁcantly inﬂuences the output (Fig. 5, also Table.
S3). For bistable range, we identiﬁed that p1 which donates basal
production rate of inactivate Bax shows strong sensitivity, while
other parameters only share relatively minor effects (Fig. 5A).
Threshold, which is also sensitive to p1 perturbations, shows even
much stronger dependence on p3 (BCL-2 production rate, Fig. 5B).
BCL-2 proteins which counteract pro-apoptotics elevate the
threshold for overall activation of Bax, thus strongly inﬂuence
threshold. Fig. 5C depicts that steady state (activated Bax) is sensi-
tive to p1 (Fig. 5C). u2 (activated Bax degradation) shows consider-
able sensitivity but is not discussed here due to variable selection
speciﬁcity (i.e. we chose activated Bax as behavior variable). Re-
sults suggest that only a small fraction is identiﬁed as sensitive
Fig. 4. ‘Variable-delay, snap-action’. (A) Distribution of normalized activation time.
(B) Distribution of normalized delay time.
Fig. 5. Mutual information index. Parameter sensitivities for (A) bistable rang
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robust bistability.
2.3.2. Steady state is refractory to parameter variation, while threshold
and bistable range are more fragile
To distinguish the refractory and fragile properties for bistabil-
ity, we depicted the favored attributes against total parameter var-
iation (TPV). Notice the same 1000 random parameter sets were
employed. The output was normalized as described in methods.
We found that the steady states are relatively refractory to varia-
tions, while threshold and bistable range ﬂuctuate violently
(Fig. S5).
2.3.3. Parametric uncertainty induced switch type transition
We have characterized robust bistability (range, threshold and
steady state) for saddle-node bifurcation. To our knowledge, when
bistable region covers the origin of the coordinates, the toggle
switch undergoes a conversion to a one-way type which refers to
irreversible activation. We further explored whether parametric
uncertainty inﬂuences switch type. Two parameters (p1 and p3)
caught our attention because they strongly inﬂuenced the thresh-
old (Fig. 5B). Also the same 1000 random parameter sets were
used. The nominal parameter set deﬁnes a toggle switch. Note that
the parameter values were normalized, thus the coordinates range
from 0.2 to 0.2. We found that in noisy environment, parametric
uncertainty does induce switch type transition due to the emer-
gence of black dots (Fig. 6). One-way switch has strong tendency
to larger p1, while increased p3 will dilute the local concentrations
for this type. For pairwise values approaching the origin (i.e. nom-
inal values for these two parameters), some individual runs even
indicate a one-way type (arrows). Therefore, parametric uncer-
tainty can reinforce switch type transition.e, (B) threshold and (C) high steady state (parameter numbers, Table S3).
Fig. 6. Switch type transition. Black: one-way switch. Grey: toggle switch.
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We investigated Bax activation switch by combined approaches
and further relate parameter uncertainty to bifurcation analysis.
Bifurcation analysis based on stochastic methods is seldom applied
but provides considerable foresights. Additionally, efﬁcient deter-
mination of sensitivity properties via random sampling can well
characterize the noisy nature of biological system.
Since BCL-2 apoptotic network is upgraded, the complex inter-
actions of BCL-2 family members motivated many theoretical stud-
ies. Previously, we identiﬁed that Bax activation constitutes a
bistable switch and direct activation mode might be more plausi-
ble [8,17]. Grills et al. described that enabler induced Bak activa-
tion is sufﬁcient, therefore showed preference to the indirect
activation [18]. Our recent work [9] captured the essential ideas
of unifying model. Later, the dual interaction mode was validated
recently [6]. Thus, we chose our recent model for further analysis.
Although previous works conﬁrm bistability theoretically [8,9],
no experimental veriﬁcation has been performed. We ﬁrst ex-
tended our previous work by investigating the two-parameter
bifurcation diagram (Fig. 2, especially the CUSP surface). More
importantly, we further showed that Bax activation is indeed bista-
ble in realistic biological system experimentally (Fig. 3). The bista-
ble Bax activation has never been directly conﬁrmed in
experiments and demonstration of which provides crucial insights
into dynamical behavior for the intrinsic apoptotic decision. Bista-
ble system guarantees a bimodal response [11], while a rigorous
consolidation argues that bimodality can also arise from monotone
systems with high ultrasensitivity [19]. However, Fig. S1 implies
that ultrasensitivity is probably not strong enough. Thus, combined
theoretical and especially experimental approaches make Bax acti-
vation system a real biologically bistable switch.
As Bax activation switch becomes biologically realistic, we need
further to characterize both dynamical patterns and robustness
properties. Firstly, we showed that Bax activation switch per se al-
lows ‘variable-delay, snap-action’. But what features determine the
variable-delay while retain a snap-action? The delay indicates the
time needed for generating enough pro-apoptotics to exhaust the
repertoire of anti-apoptotics (i.e. Bcl-2 protein pool in our model)
and thus Td indicates the time needed for the initiation of apoptosis
(i.e. initiation phase). During the early initiation phase, although
the pro-apoptotics expression rate (e.g. activator in our model
when stimulated, a large p2) is elevated, cells have not accumu-
lated sufﬁcient pro-apoptotics to use up the Bcl-2 pool due to lim-
ited time period. The random ‘birth and death’ [20] of proteins
have little effects because the vast majorities of Bcl-2 pool over
proapoptotic pool mask any proapoptotic effects by fast associat-
ing the ‘new born’ activator (or ensuing activated Bax) and rapidlyshut down the ‘unpleasant’ responses (i.e. the overwhelming anti-
apoptotic pool masks proapoptotic random events and transition
from low to high state is not allowed). As time goes on, the newly
synthesized activator proteins (and/or activated Bax) keep con-
suming the Bcl-2 pool, therefore the Bcl-2 pool shrinks. In late ini-
tiation process, however, the Bcl-2 pool is near exhausted. It is
during this time period that random ‘birth-and-death’ (both pro-/
anti-apoptotics) signiﬁcantly affects systematic responses because
once proapoptotic pool surmounts the barrier of Bcl-2 pool, a tran-
sition will occur. As ‘birth-and-death’ process is stochastic, an
occasional ‘far-exceeded-average’ production of pro-apoptotics
may counteract the anti-apoptotic effects and invokes a transition
(i.e. from low to high state, short Td), while in some cases, a ‘far-ex-
ceeded-average’ production of Bcl-2 will totally mask the proapop-
totic transition and cells have to synthesize pro-apoptotics for
some more time to overcome the barrier (i.e. longer Td). Also the
random degradation behaves similarly. Only when both proapop-
totic and anti-apoptotic pools become comparable can random
‘birth and death’ have substantially stochastic effects. Thus, sto-
chastic events in late initiation phase lead to the highly variable
Td. Once effector phase (i.e. after Ta starts) is triggered, the total
pro-apoptotics has signiﬁcantly exceeded the amount of Bcl-2 pool
and all cells transit to high state. Meanwhile, during this transition,
two positive feedback loops [9] not only quicken the transition but
also highly rejected intracellular noises [21]. Thus, it is the over-
whelming multiple positive feedback loops that determine the less
variable Ta and fast transition. Then, what are the biological impli-
cations of ‘variable-delay, snap-action’? Activated Bax can form oli-
gomerized pores to trigger MOMP, thus Td can approximate the
time needed to enter apoptosis. The highly variable Td indicates
that for speciﬁc death stimulus, cells respond heterogeneously
and take different time to initiate Bax activation (i.e. longer delay
donates lower sensitivity to apoptosis). Treatment of cells with
survival signals may counteract the death signals if apoptosis is
not decided [22]. When applying survival agents before Ta starts
(Fig. S3, point A), cells will undergo remission from apoptosis,
while after activation process begins, death will be irreversible
(point B). Therefore, the ‘variable-delay’ gives a plausible explana-
tion to the cell-to-cell variability (i.e. different sensitivities to proa-
poptotic stimuli). On the other hand, as activation starts (Ta start
point), the levels of activated Bax and concomitant Bax pores
should incur abrupt elevation, thus ensure fast death decision. If
the activation time (Ta) takes longer, cells will deﬁnitely have lar-
ger probabilities running the risk of partial cell death (i.e. cells ini-
tiate and fail to complete death). The incomplete death will lead to
genome instability which makes cells more cancer-prone [23].
Hence, intrinsic apoptotic pathway demands fast switching. Re-
cently Düssmann et al. found that Bax activation and oligomeriza-
tion started only minutes before or concomitantly with MOMP, and
further identiﬁed that minimal Bax or Bak activation may be sufﬁ-
cient to trigger rapid pore formation [24]. As MOMP represents
decisive apoptotic events [1,2], the starting time for Bax activation
(Td end point) can well approximate the delay needed for apoptosis
initiation. The concomitant events of Bax activation and MOMP
strongly indicate a perfect ‘snap-action’ experimentally. Therefore,
it is the time delay (Td) that characterizes the sensitivity of individ-
ual cells and dictates cell fate and intrinsic apoptotic pathway can
behave as a perfect switch.
Bifurcation analysis based on parameter variations identiﬁed
that even 30% simultaneous perturbation does not change the
bistable responses at all. Therefore, we found that the robustness
of Bax activation switch was intensively underestimated in our
previous work [9] and intrinsic pathway is indeed robust. Mutual
information indicates that bistability is relatively insensitive to
most parameters, a subset of which characterizes kinetic rates
for association and dissociation. As we know, BH3-only and
T. Sun et al. / FEBS Letters 584 (2010) 954–960 959anti-apoptotics differ signiﬁcantly in association and dissociation
potency [25], but our results suggested that the topological struc-
ture of BCL-2 network per se can confer bistability, no matter what
subsets of members are in charge, thus conferring robustness to
mitochondrial apoptotic pathway. As Bax activation switch partic-
ipates in intrinsic apoptotic pathway, and upregulation of which
will contribute to tumor cell depletion [26], further identifying
the fragile components in Bax activation switch undoubtedly pro-
vides critical insights into clinical and pharmacological manipula-
tion. We found only a few parameters signiﬁcantly inﬂuence
bistability. First, except for u2 due to variable selection, we showed
only p1 strongly affects the bistability constantly. As p1 represents
Bax production, we suggest manipulation of highly sensitive
parameters would be far more efﬁcient in controlling apoptosis.
Some reports suggested that overexpression of Bax induces tumor
cell apoptosis [27,28], which is well consistent with our specula-
tion. Second, we found p3 greatly inﬂuences threshold. Threshold
has important implications because life beneﬁts from lowering it
in tumor-prone cells, and raising it when functional tissues become
hypersensitive. Many reports identiﬁed that the control over anti-
apoptotics expression substantially regulates apoptosis [29,30].
Thus, the robust and fragile properties shed light on in-depth
knowledge about intrinsic apoptotic pathway.
Further we identiﬁed ﬂuctuated threshold, bistable range but
relatively concise steady states (Fig. S5) under simultaneous
parameter perturbation. As the threshold (SN2, Fig. S4) sets the
critical point where pro-apoptotics can exceed the amount of
anti-apoptotics, any parameter that could potentially regulate the
anti-/pro-apoptotic ratio (anti-: Bcl-2, and pro-: enabler, activator
and activated Bax, the three subsets that bind Bcl-2) can inﬂuence
the threshold. Nearly all parameters (or reactions) directly inﬂu-
ence the anti-/pro-apoptotic ratio (i.e. by regulating anti-/pro-
apoptotic proteins). The bistable range, which covers the random
ﬂuctuations of both SN1 and SN2, is undoubtedly more heteroge-
neous under total parameter variation. When reaching the high
steady state, pro-apoptotics must have exhausted the anti-apopto-
tic pool and incurred a transition. After reaching high steady state
(i.e. the level of activated Bax becomes overwhelming), only the
subset of parameters that directly inﬂuences the level of activated
Bax has substantial effects. Therefore, only activation and deactiva-
tion/degradation rates fulﬁll this role and signiﬁcantly inﬂuence
the steady state of activated Bax conferring less ﬂuctuation. The
highly variable threshold may also characterize the cell-to-cell var-
iability under stressed condition from another perspective. How-
ever, the highly ﬂuctuated steady state of activated Bax seems
unnecessary because minimal activation can ensure efﬁcient kill-
ing [24]. We further detected one-way switch even close to nomi-
nal value, thus further consolidated the highly variable cellular
responses.
Apoptotic network has been extensively modeled in recent
years. Eissing et al. investigated the extrinsic pathway and set a
framework for analyzing apoptotic network [31]. Later, Bagci
et al. explored both pathways and found that cooperative apopto-
some assembly is essential for bistability [32]. But they did not
indicate whether intrinsic pathway per se is bistable. More impor-
tantly, no direct experimental consolidation of bistable Bax activa-
tion appears previously. Our experimental result does show that
Bax activation is bistable, therefore making the BCL-2 regulatory
pathway a biologically bistable switch. We also elucidated multi-
ple sources for cell-to-cell variability (i.e. intrinsic noises and
parameter uncertainty). Furthermore, we identiﬁed that topologi-
cal structure per se can guarantee bistability, and the bistability
of Bax activation switch is tremendously robust. Except for the
robustness properties, we further investigate the fragile compo-
nents in Bax activation switch and provide crucial foresights into
physiological intervention.Pivotal roles of BCL-2 regulatory network may create a fertile
ground for both theoretical and experimental investigation. Not-
withstanding limitations, we expect that our approaches will be re-
ﬁned and more valuable in future.
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